Baillie Gifford & CO Royalty Pharma PLC Transaction History
Baillie Gifford & CO
- $111 Billion
- Q1 2025
A detailed history of Baillie Gifford & CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Baillie Gifford & CO holds 13,402,284 shares of RPRX stock, worth $450 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
13,402,284
Previous 14,134,516
5.18%
Holding current value
$450 Million
Previous $361 Million
15.71%
% of portfolio
0.38%
Previous 0.28%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.38 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$773 Million0.01% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$408 Million0.39% of portfolio
-
Viking Global Investors LP10.6MShares$355 Million1.1% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...